← Eichor
Study identifier: NCT07146776 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Treatment of Intrabony Defects With Injectable Platelet-Rich Fibrin and Xenogenic Grafts

Condition: Periodontitis · Intrabony Periodontal Defect · Periodontal Diseases  ·  Sponsor: Saglik Bilimleri Universitesi

PhaseNA
Planned participants16
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

The use of injectable platelet-rich fibrin (i-PRF) in both surgical and non-surgical dental treatments has become increasingly widespread. Hard tissue grafts can produce "sticky bone," and bone gain can have a positive effect on intrabony defects frequently seen in periodontal disease, compared to grafts alone. This study aims to clinically and radiographically evaluate the effectiveness of using bovine-derived xenogenic bone grafts in combination with i-PRF and bovine-derived xenogeneic bone grafts alone in patients with intrabony defects and stage III periodontitis.

This description comes directly from the study's public registry record.

Talk to the study team

Tuğçe Paksoy, Associate Professor  ·  +905534490452  ·  tugceakap86@hotmai.com

Alima Budakçı  ·  +905319841597  ·  alima-97@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Sağlık Bilimleri ÜniversitesiIstanbul, Üsküdar, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07146776